Search Results - "Jordan, Shaun"
-
1
The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor
Published in European journal of pharmacology (26-04-2002)“…Aripiprazole, 7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy]-3,4-dihydro-2(1H)-quinolinone, a novel antipsychotic with partial agonist activity at…”
Get full text
Journal Article -
2
Aripiprazole protects cortical neurons from glutamate toxicity
Published in European journal of pharmacology (25-01-2011)“…Neurodegeneration is thought to be a component of schizophrenia pathology, and some antipsychotics appear to slow degenerative changes in patients…”
Get full text
Journal Article -
3
In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function
Published in European journal of pharmacology (01-01-2004)“…In vivo microdialysis was used to monitor the effects of oral aripiprazole and olanzapine on basal extracellular concentrations of dopamine,…”
Get full text
Journal Article -
4
Dopamine D2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D2 receptor signaling
Published in Progress in neuro-psychopharmacology & biological psychiatry (30-03-2007)“…Clinical evidence suggests that dopamine D(2) receptor partial agonists must have a sufficiently low intrinsic activity to be effective as antipsychotics…”
Get full text
Journal Article -
5
6-[ 18F]Fluoro- l- m-tyrosine: metabolism, positron emission tomography kinetics, and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lesions in primates
Published in Brain research (07-03-1997)“…The tracer 6-[ 18F]fluoro- l- m-tyrosine (FMT) was studied with regard to its biochemistry and kinetics, as well as its utility in evaluating brain…”
Get full text
Journal Article -
6
Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT2A receptors : functional receptor-binding and in vivo electrophysiological studies
Published in Psychopharmacologia (01-02-2007)“…Background Aripiprazole (7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy}-3,4-dihydro-2(1H)-quinolinone) is a novel antipsychotic with a mechanism of action…”
Get full text
Journal Article -
7
Acthar gel treatment suppresses acute exacerbations in a murine model of relapsing-remitting multiple sclerosis
Published in Autoimmunity (Chur, Switzerland) (01-06-2015)“…Abstract Acthar gel is indicated for the treatment of acute exacerbations of multiple sclerosis (MS) in adults. Its effects on immune cells during a relapse…”
Get full text
Journal Article -
8
In vitro biochemical evidence that the psychotomimetics phencyclidine, ketamine and dizocilpine (MK-801) are inactive at cloned human and rat dopamine D2 receptors
Published in European journal of pharmacology (01-07-2006)“…Dopamine potently increased calcium mobilization in Chinese hamster ovary cells expressing human dopamine D2Long receptors (CHO-D2L cells), and increased…”
Get full text
Journal Article -
9
Dopamine D 2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D 2 receptor signaling
Published in Progress in neuro-psychopharmacology & biological psychiatry (30-03-2007)“…Clinical evidence suggests that dopamine D 2 receptor partial agonists must have a sufficiently low intrinsic activity to be effective as antipsychotics. Here,…”
Get full text
Journal Article -
10
In vitro biochemical evidence that the psychotomimetics phencyclidine, ketamine and dizocilpine (MK-801) are inactive at cloned human and rat dopamine D 2 receptors
Published in European journal of pharmacology (01-07-2006)“…Dopamine potently increased calcium mobilization in Chinese hamster ovary cells expressing human dopamine D 2Long receptors (CHO-D 2L cells), and increased…”
Get full text
Journal Article -
11
In vitro functional characteristics of dopamine D2 receptor partial agonists in second and third messenger-based assays of cloned human dopamine D2Long receptor signalling
Published in Journal of psychopharmacology (Oxford) (01-08-2007)“…Aripiprazole, (+)terguride, OPC-4392 and (—)3-PPP have been classified as dopamine D2 receptor partial agonists based largely on their activity in second…”
Get full text
Journal Article -
12
In vitro functional characteristics of dopamine [D.sub.2] receptor partial agonists in second and third messenger-based assays of cloned human dopamine [D.sub.2Long] receptor signaling
Published in Journal of psychopharmacology (Oxford) (01-10-2007)“…Aripiprazole, (+)terguride, OPC-4392 and (-)3-PPP have been classified as dopamine [D.sub.2] receptor partial agonists based largely on their activity in…”
Get full text
Journal Article -
13
In vitro functional characteristics of dopamine D^sub 2^ receptor partial agonists in second and third messenger-based assays of cloned human dopamine D^sub 2Long^ receptor signalling
Published in Journal of psychopharmacology (Oxford) (01-08-2007)“…Aripiprazole, (+)terguride, OPC-4392 and (-)3-PPP have been classified as dopamine Dsub2 receptor partial agonists based largely on their activity in second…”
Get full text
Journal Article -
14
In vitro biochemical evidence that the psychotomimetics phencyclidine, ketamine and dizocilpine (MK-801) are inactive at cloned human and rat dopamine D sub(2) receptors
Published in European journal of pharmacology (01-07-2006)“…Dopamine potently increased calcium mobilization in Chinese hamster ovary cells expressing human dopamine D sub(2Long) receptors (CHO-D sub(2L) cells), and…”
Get full text
Journal Article -
15
Dopamine D sub(2) receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D sub(2) receptor signaling
Published in Progress in neuro-psychopharmacology & biological psychiatry (01-03-2007)“…Clinical evidence suggests that dopamine D sub(2) receptor partial agonists must have a sufficiently low intrinsic activity to be effective as antipsychotics…”
Get full text
Journal Article -
16
In vitro profile of the antidepressant candidate OPC-14523 at rat and human 5-HT sub(1A) receptors
Published in European journal of pharmacology (01-07-2005)“…This study determined the in vitro functional profile of 1-[3-[4-(3- chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinol inone…”
Get full text
Journal Article -
17
Altered emotional behaviors in the diabetes mellitus OLETF type 1 congenic rat
Published in Brain research (31-10-2007)“…Abstract GPR10 is a G-protein-coupled receptor expressed in thalamic and hypothalamic brain regions, including the reticular thalamic nucleus (RTN) and…”
Get full text
Journal Article -
18
In vitro profile of the antidepressant candidate OPC-14523 at rat and human 5-HT 1A receptors
Published in European journal of pharmacology (2005)“…This study determined the in vitro functional profile of 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinolinone…”
Get full text
Journal Article -
19
In vitro profile of the antidepressant candidate OPC-14523 at rat and human 5-HT1A receptors
Published in European journal of pharmacology (11-07-2005)“…This study determined the in vitro functional profile of 1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2-quinolinone…”
Get full text
Journal Article -
20
Interaction of the novel antipsychotic aripiprazole with 5-HT sub(1A) and 5-HT sub(2A) receptors: functional receptor-binding and in vivo electrophysiological studies
Published in Psychopharmacology (01-02-2007)“…Background: Aripiprazole (7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy}-3,4-dihydro-2( 1 H)-quinolinone) is a novel antipsychotic with a mechanism of…”
Get full text
Journal Article